close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by RevolKa Ltd.

News headline image
RevolKa Reimagines Antibody Engineering with "RevoAb®"
From RevolKa Ltd.
Via Business Wire
News headline image
'RevoAb™', A New Service for Antibody Developability Engineering
From RevolKa Ltd.
Via Business Wire
News headline image
RevolKa Ltd. Joins Research and Development Program for Innovative Biologics Funded by the Japanese Agency for Medical Research and Development (AMED)
From RevolKa Ltd.
Via Business Wire
News headline image
RevolKa Ltd. Secures 210 million JPY (US$1.4 million) Series A Extension Funding to Advance Therapeutic Programs
From RevolKa Ltd.
Via Business Wire
News headline image
RevolKa Ltd. Announces the Closing of a 250 Million JPY (US$1.7 Million) Series A Extension Funding to Accelerate Drug-Discovery Programs
From RevolKa Ltd.
Via Business Wire
News headline image
RevolKa Signed Master Service Agreement with Daiichi Sankyo
From RevolKa Ltd.
Via Business Wire
News headline image
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
From RevolKa Ltd.
Via Business Wire
News headline image
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
From RevolKa Ltd.
Via Business Wire
News headline image
RevolKa Ltd.: Announcement of Milestone Achievement in the Collaborative Research with Sumitomo Pharma Co., Ltd.
From RevolKa Ltd.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today